CA
ORGO icon

Clearstead Advisors’s Organogenesis Holdings ORGO Stock Holding History

Clearstead Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02K Buy
+419
New +$1.02K ﹤0.01% 2679
2025
Q4 		– Sell
-13
Closed -$55 – 3112
2025
Q3 		$55 Buy
+13
New +$60 ﹤0.01% 2972

Other funds holding ORGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Clearstead Advisors's ORGO Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 419 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #2679 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ORGO as recently as Q3 2025.

Clearstead Advisors first reported a position in ORGO in Q3 2025 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Clearstead Advisors held 419 shares of Organogenesis Holdings worth $1.02K as of Q2 2026.
  • Organogenesis Holdings was a new Clearstead Advisors position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2679 holding.
  • Clearstead Advisors first reported a position in Organogenesis Holdings in Q3 2025 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.